Literature DB >> 9845734

Primary pulmonary ganglioneuroblastoma: a clinicopathologic and immunohistochemical study of two cases.

L Hochholzer1, C A Moran, M N Koss.   

Abstract

We present two patients with primary ganglioneuroblastoma involving the bronchial wall. The first, a 38-year-old woman, presented with signs and symptoms suggestive of multiple endocrine neoplasia, including gastric ulceration and hypercalcemia. Chest radiographic studies revealed a 3-cm nodule in the hilus of the right lung and two less-pronounced lesions in the periphery of the right lung. The second, a 20-year-old asymptomatic woman, was evaluated for a solitary mass in the upper lobe of the left lung that was peribronchial and that impinged on the lumen of a bronchus. Grossly, both neoplasms extended from bronchi, were well-circumscribed, firm, tan or white, and homogeneous, and measured 5 x 5 cm and 3 x 3 cm, respectively. Histologically, both tumors were characterized by neuroblastoma with areas of neuropil and multifocal areas of ganglion cells. Immunohistochemical studies performed in one case showed focal staining for neurofilament protein and S-100 protein and diffuse staining for neuron-specific enolase. Follow-up information showed that one patient died a few days after admission to the hospital; the second patient has remained well and without evidence of recurrence or metastases 1 year after initial diagnosis. These two cases confirm that ganglioneuroblastoma can occur as a primary pulmonary tumor in adults, presumably arising from sympathetic ganglia of the bronchus.

Entities:  

Mesh:

Year:  1998        PMID: 9845734     DOI: 10.1016/s1092-9134(98)80002-6

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  1 in total

1.  Adult-onset ganglioneuroblastoma of the posterior mediastinum with osseous metastasis.

Authors:  Ahmad M Mousa; Mohammad H Shokouh-Amiri; Love M Shah; Steven Garzon; Karen L Xie
Journal:  Radiol Case Rep       Date:  2020-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.